BVMFBALM3
Market cap19mUSD
Dec 19, Last price
12.40BRL
1D
-3.43%
1Q
0.00%
Name
Baumer SA
Chart & Performance
Profile
Baumer S.A. develops solutions in hospitals, odontology, and health industry equipment in Brazil, Europe, Asia, and the United States. It offers sterilization and infection control solutions, such as steam sterilizers, formoldehyde and hydrogen peroxide steam sterilizers, solid waste treatment systems, ethylene oxide sterilizers, thermal washer disinfectors, drying cabinets, ultrasonic reprocessors, preparation and storage systems, loading and water treatment systems, test and control, and steam generators. The company also provides surgical center solutions, including anesthesia systems, lighting products, and surgical tables; and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as pedicle fixation system, occipitocervial fixation systems, cervical cage angled, and posterior lumbar cages. Further, the company offers dental solutions, including implants and biomaterials. It serves hospitals, clinics, hemocenters, universities, public health service, and carrier health markets; and pharmaceutical, food, and cosmetics industries, as well as research institutes and laboratories. The company was founded in 1952 and is based in Pacaembu, Brazil.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 169,950 -48.36% | 329,088 22.96% | 267,640 -17.89% | |||||||
Cost of revenue | 146,650 | 141,728 | 120,806 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 23,300 | 187,360 | 146,834 | |||||||
NOPBT Margin | 13.71% | 56.93% | 54.86% | |||||||
Operating Taxes | 5,673 | 3,968 | 3,297 | |||||||
Tax Rate | 24.35% | 2.12% | 2.25% | |||||||
NOPAT | 17,627 | 183,392 | 143,537 | |||||||
Net income | 8,940 56.59% | 5,709 -43.65% | 10,132 -38.34% | |||||||
Dividends | (4,796) | (4,846) | ||||||||
Dividend yield | 4.90% | 3.82% | ||||||||
Proceeds from repurchase of equity | 26 | (4,058) | 831 | |||||||
BB yield | -0.02% | 4.15% | -0.65% | |||||||
Debt | ||||||||||
Debt current | 3,791 | 6,673 | 6,199 | |||||||
Long-term debt | 16,340 | 18,983 | 15,525 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 23,477 | 841 | 1,023 | |||||||
Net debt | (73,374) | 13,365 | 5,306 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 25,593 | 3,133 | 17,635 | |||||||
CAPEX | (5,423) | (6,078) | (4,810) | |||||||
Cash from investing activities | (5,298) | (3,316) | (4,172) | |||||||
Cash from financing activities | (4,154) | (489) | (1,102) | |||||||
FCF | 27,182 | 173,781 | 124,704 | |||||||
Balance | ||||||||||
Cash | 59,462 | 43,320 | 43,992 | |||||||
Long term investments | 34,043 | (31,029) | (27,574) | |||||||
Excess cash | 85,008 | 3,036 | ||||||||
Stockholders' equity | 145,599 | 134,590 | 131,723 | |||||||
Invested Capital | 104,370 | 159,081 | 149,485 | |||||||
ROIC | 13.38% | 118.87% | 101.58% | |||||||
ROCE | 12.18% | 102.22% | 84.68% | |||||||
EV | ||||||||||
Common stock shares outstanding | 9,785 | 9,785 | 9,785 | |||||||
Price | 11.52 15.20% | 10.00 -22.96% | 12.98 -17.32% | |||||||
Market cap | 112,718 15.20% | 97,845 -22.96% | 127,003 -17.33% | |||||||
EV | 40,703 | 112,262 | 133,810 | |||||||
EBITDA | 28,168 | 191,466 | 151,442 | |||||||
EV/EBITDA | 1.44 | 0.59 | 0.88 | |||||||
Interest | 9,564 | 1,453 | 1,636 | |||||||
Interest/NOPBT | 41.05% | 0.78% | 1.11% |